Additionally, weight loss itself can improve conditions such as obstructive sleep apnoea, potentially leading to better sleep quality over time
Heffron and his team began with a comprehensive literature search for randomized, controlled trials involving adults with obesity or diabetes or both treated with GLP-1 agonists for at least six months
What injection site reactions should concern me
This is in keeping with a recent study reporting 24 h BP measurements on tirzepatide, a dual GLP-1 RA and glucose-dependent insulinotropic polypeptide (GIP) analogue, which suggested that 70% its BP effect was mediated by body weight reduction
Naghibalhossaini F, Mokarram P, Khalili I, Vasei M, Hosseini SV, Ashktorab H, Rasti M, Abdollahi K
10.1042/0264-6021:3480607 95 PandeyA.VermaS.KumarV